Mini review · 13 Feb 2026
Conference abstractPublished 29 Oct 2018
Prognosis and response to therapy can be efficiently predicted by a combination of cytogenetic aberrations, detected by interphase-FISH in newly diagnosed multiple myeloma patients
Tata Memorial Centre, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Multiple myelomas (MM) is a cytogenetically heterogenous plasma cell malignancy. The detection and interpretation of cytogenetic abnormalities in MM is of critical importance for prognosis and risk stratification. Objectives: To determine the role of cytogenetic aberrations in classification, risk stratification and predicting therapy response in Indian population. Material and Methods: Retrospective interphase FISH analysis on CD138 positive plasma cells was carried out in 342 de novo multiple myeloma patients. Results: Cytogenetic abnormalities by FISH were detected in 65% (221/342) patients. Monosomy 13/del(13q) was observed in 35% patients followed by hyperdiploidy in 33%, IgH translocations in 30%, gain(1q21) in 21% and monosomy 17/TP53 deletion in 7% patients. Our patients presented lower median age, 55.5 years, which is a decade younger than those from other countries. Low prevalence of chromosome 13 aberrations (35%) and t(11;14) (4%) was observed, as compared to the Western population probably due to geographic heterogeneity. IgH translocation group and TP53 deletion were identified as a high-risk group due to correlation with advanced disease; ISS stage III, whereas chromosome 13 aberrations were associated with high plasma cells. Complete response (CR) and very good partial response (VGPR) was observed in patients without high-risk cytogenetic abnormalities: t(4;14), t(14;20) and gain(1q21). Conclusions: Deletion(17p13), t(4;14), t(14;20) and gain(1q21) were independent high-risk prognostic factors, can predict lower response rates to therapy, are more likely to relapse early, thus need more intensive treatments. Interphase-FISH can efficiently detect poor prognostic markers thus helping in risk stratification aiding in treatment decisions and better patient management.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Hematology & Thromboembolic Diseases.
Opinion · 25 Dec 2025
Clinical Patterns and Systemic Implications of Thromboembolism
Opinion · 25 Dec 2025
Integrating Clinical Risk and Preventive Care in Thromboembolism Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Hematology & Thromboembolic Diseases
- SubjectHaematology
- BylineArticles whose byline prints “Hemani Jain”
